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OBJECTIVE — To evaluate the effects of hyperglycemia due to partial insulin deprivation on
myocardial triglyceride (TG) content and myocardial function in patients with type 1 diabetes.
RESEARCH DESIGN AND METHODS — Myocardial and hepatic TG content and left
ventricular (LV) function were measured by magnetic resonance (MR) spectroscopy and MR
imaging during optimal glucoregulation and after 24 h of partial insulin deprivation (n  10).
RESULTS — Mean insulin infusion rate was 45  5 units at baseline, whereas it was 27  5
units during hyperglycemia (per 24 h, P  0.001). Plasma glucose levels increased from 8.4 
0.6to15.90.8mmol/l(P0.001),andplasmalevelsofnonesteriﬁedfattyacidsfrom0.31
0.05to0.460.07mmol/l(P0.015).Hyperglycemiahadnoeffectsonmyocardialorhepatic
TG content and LV function.
CONCLUSIONS — Short-termhyperglycemicdysregulationdoesnotmodulatemyocardial
or hepatic TG content or myocardial function, despite considerable metabolic adaptations.
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I
ntramyocellular triglyceride (TG) con-
tent in skeletal muscle is increased in
patientswithtype1diabetescompared
with that in control subjects (1), suggest-
ing a major role of metabolic dysregula-
tion in the induction of abnormal
intramyocellular lipid accumulation in
type 1 diabetes. Recent optimalization of
magnetic resonance (MR) spectroscopy
techniques allowed us to study myocar-
dial TG content and myocardial function
in vivo and to document an inverse rela-
tionship between myocardial TG content
and myocardial function in healthy sub-
jects (2). Therefore, we hypothesized that
episodes of metabolic dysregulation due
to insufﬁcient insulin provision may ad-
versely affect myocardial TG content and
myocardial function.
RESEARCH DESIGN AND
METHODS— MR imaging and MR
spectroscopy were performed twice in 10
C-peptide–negative, nonsmoking pa-
tients with type 1 diabetes (ﬁve male) us-
ing insulin treatment by insulin pump
therapy (continuous subcutaneous insu-
lin infusion). No participant showed evi-
dence of cardiovascular disease. The
study was designed to mimic hyperglyce-
mic dysregulation in daily life. Therefore,
thesubjectswereinstructedtoretaintheir
daily routine. One study was done after a
3-day period in which subjects aimed at
optimalbloodglucoselevelsmeasuredby
a continuous glucose monitoring system
(Medtronic). The second study was per-
formed after 50% reduction in basal
and bolus insulin infusions during 24 h,
compared with the ﬁrst study, in order to
maintainhyperglycemiawithglucoselev-
els between 15 and 20 mmol/l. For both
occasions, patients were instructed to
maintain the same caloric intake for 3
days before examination. The sequence
between the euglycemic and hyperglyce-
mic occasions was randomly assigned.
Before MR examination, blood samples
(postprandial)weretaken.Anethicscom-
mittee approved the study, and subjects
signed informed consent.
MR spectroscopy measurements
(1.5-T; Philips) were obtained using a
point-resolved, spatially localized spec-
troscopicpulsesequencetoacquiresingle
voxel (8 ml) spectra. For the heart, data
acquisition was double triggered (electro-
cardiogram triggering and navigator ech-
oes [3]). For the liver, voxel sites were
matchedatthestudyoccasions.Lipidres-
onances of myocardial and hepatic TG
were summed and calculated as a per-
centage of the unsuppressed water signal
([TG/water]  100).
To assess left ventricular (LV) systolic
function, the heart was imaged in the
short axis orientation. To assess LV dia-
stolic function, a phase contrast sequence
with velocity encoding was performed to
measure blood ﬂow across the mitral
valve (4). Analysis was performed using
MASS and FLOW (Medis) to quantify LV
ejection fraction and ﬂow velocities in
early diastole (early ﬁlling phase [E]) and
at atrial contraction (atrial ﬁlling phase
[A], E/A ratio, and E deceleration).
Data were compared by paired t test
and are shown as mean  SEM. P  0.05
was considered to reﬂect signiﬁcant
differences.
RESULTS— Patient characteristics at
baseline and during hyperglycemia are
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plasma 24-h glucose was 8.4  0.6
mmol/l during the control study, which
increased to 15.9  0.8 mmol/l during
partial insulin deprivation [P  0.001])
and associated with an increase in plasma
levels of nonesteriﬁed fatty acids from
0.31  0.05 to 0.46  0.07 mmol/l (P 
0.015). Myocardial TG content was
0.31  0.04% at baseline and did not
change during hyperglycemic dysregula-
tion(0.340.06%;P0.587).E/Aratio
was unaffected (1.9  0.2 at baseline vs.
1.9  0.3).
CONCLUSIONS — This is the ﬁrst
study to document the effects of short-
term hyperglycemic dysregulation on
myocardial TG content and LV function
in patients with type 1 diabetes. The
present study shows that hyperglycemic
dysregulation for 24 h, as frequently ob-
served in patients with type 1 diabetes,
does not modulate myocardial TG con-
tent or myocardial function, despite con-
siderable metabolic dysregulation.
Wehypothesizedthatshort-termpar-
tial insulin deprivation results in changes
in myocardial TG content, possibly asso-
ciated with changes in myocardial func-
tion. Stiffness of intermediate-sized
arteries is rapidly increased in patients
with type 1 diabetes during hyperglyce-
mia, whereas larger arteries seem unaf-
fected (5). Moreover, in healthy subjects
myocardial function and TG content rap-
idly adapt to changes in metabolic state
(2). Interestingly, this adaptation could
not be evoked by short-term hyperglyce-
mic dysregulation, suggesting that the
heart is protected from these short-term
effects. Nonetheless, we cannot exclude
the possibility that prolongation of the
duration of partial insulin deprivation
might have resulted in changes in myo-
cardial function and TG content.
Patients with type 1 diabetes have
considerably altered myocardial glucose
and fatty acid metabolism. Myocardial
fatty acid utilization is increased, whereas
myocardial glucose uptake is consider-
ably lower in diabetic patients compared
with that in control subjects (6). These
adaptations protect the heart-to-substrate
overﬂow of the myocardium. Accord-
ingly, the present study interestingly
shows that myocardial TG content in di-
abetic patients was not different from the
values we observed in studies in healthy
subjects (2,3). However, fatty acid kinet-
ics during hyperglycemia cannot be de-
rived from the present data, and we
cannot exclude changes in myocardial
fatty acid oxidation.
Hepatic TG content was measured to
study the effects of insulin deprivation on
tissue-speciﬁc TG distribution because
we previously found discrepant effects of
interventionsonheartandliver(2).How-
ever, in the present study design insulin
deprivation did not result in altered he-
patic TG content.
In conclusion, short-term partial in-
sulin deprivation resulting in hyperglyce-
mic dysregulation, which is frequently
observed in patients with type 1 diabetes,
does not modulate myocardial or hepatic
TG content or LV function, despite con-
siderable metabolic dysregulation.
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Age (years) 41  3——
A1C (%) 7.4  0.2 — —
Duration of diabetes (years) 21.7  2.3 — —
BMI (kg/m
2) 23.5  0.6 23.0  0.8 0.1
Mean 24-h glucose (mmol/l) 8.4  0.6 15.9  0.8  0.001
Mean 24-h insulin (units/l) 45  52 7  5  0.001
NEFAs (mmol/l) 0.31  0.05 0.46  0.07 0.015
TG (mmol/l) 1.03  0.24 0.85  0.49 0.2
Total cholesterol (mmol/l) 4.3  0.2 4.4  0.2 0.1
Systolic blood pressure (mmHg) 114  4 118  5 0.2
Diastolic blood pressure (mmHg) 68  37 3  3 0.1
Heart rate (bpm) 63  16 0  3 0.3
MR spectroscopy
Liver TG content (%) 0.77  0.09 0.84  0.11 0.4
Myocardial TG content (%) 0.31  0.04 0.34  0.06 0.6
MR imaging
LV ejection fraction (%) 58  15 9  2 0.6
E peak ﬁlling rate (ml/s) 475  21 467  20 0.6
E deceleration (ml/s
2  10
3) 4.4  0.4 4.5  0.3 0.8
A peak ﬁlling rate (ml/s) 267  21 254  38 0.7
E/A peak ratio 1.9  0.2 1.9  0.3 0.9
Data are means  SEM. Blood samples were obtained 2 h after the last meal. NEFA, nonesteriﬁed fatty acid.
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